Table 2.
Mean value levels (ng/ml) of Interleukin 1-beta (IL-1β), Interleukin 6 (IL-6), and Interleukin 10 (IL-10) before treatment, 7 weeks after the start of treatment, 3 and 12 months after the termination of treatment in patients with head and neck cancer.
| Treatment | Before | 7 weeks | 3 months | 12 months |
|---|---|---|---|---|
| IL-1β | ||||
| CRT | 0.0045 | 0.1523 | 0.0136 | 0.0150 |
| CRT+surgery | 0.0123 | 0.0171 | 0.0014 | 0.0078 |
| RT+surgery | 0.0092 | 0.0098 | 0.0059 | 0.0180 |
| RT | 0.0061 | 0.0085 | 0.0061 | 0.0122 |
| Surgery | 0.0019 | 0.0133 | 0.0028 | 0.0052 |
| IL-6 | ||||
| CRT | 0.2325 | 3.3606 | 0.0431 | 0.3774 |
| CRT+surgery | 0.1295 | 1.4183 | 0.0769 | 0.3075 |
| RT+surgery | 0.2131 | 0.4077 | 0.1307 | 0.5104 |
| RT | 0.0567 | 0.3296 | 0.1849 | 0.1413 |
| Surgery | 0.0187 | 0.0657 | 0.0466 | 0.4650 |
| IL-10 | ||||
| CRT | 0.3857 | 3.0287 | 0.3253 | 0.4264 |
| CRT+surgery | 0.2870 | 1.5778 | 0.2715 | 0.3460 |
| RT+surgery | 0.3762 | 0.5309 | 0.3224 | 0.4739 |
| RT | 0.2553 | 0.4822 | 0.2699 | 0.3596 |
| Surgery | 0.2699 | 0.2401 | 0.2367 | 0.4946 |
CRT, chemoradiotherapy; RT, radiotherapy.